GLP1R/GIPR/GCGR small molecule (Cascade Pharma)

N/A

Report date: 2026/04/09 20:00:21

NME

Base Information

Drug NameGLP1R/GIPR/GCGR small molecule (Cascade Pharma)

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionGlucagon-like peptide 1 receptor modulatorsGlucose-Dependent Insulinotropic Polypeptide Receptor modulatorsGlucagon receptor modulators

TargetsGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide ReceptorGlucagon receptor

Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesCascade Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesCascade Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsObesityDiabetes Mellitus, Type 2

Inactive IndicationsN/A

Other Information

ATC CodeN/A